North America Longevity Diagnostics Market Size & Outlook
Related Markets
North America longevity diagnostics market highlights
- The North America longevity diagnostics market generated a revenue of USD 1,321.8 million in 2025.
- The market is expected to grow at a CAGR of 6% from 2026 to 2033.
- In terms of segment, epigenetic age testing was the largest revenue generating test type in 2025.
- Multi-Omics Profiling is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 1,321.8 million |
| Market revenue in 2033 | USD 2,080.1 million |
| Growth rate | 6% (CAGR from 2026 to 2033) |
| Largest segment | Epigenetic age testing |
| Fastest growing segment | Multi-Omics Profiling |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epigenetic Age Testing, Telomere Length Analysis, Multi-Omics Profiling, Proteomics-Based Aging Biomarkers, Metabolomics Testing, Microbiome Aging Diagnostics, Hormone & Metabolic Profiling |
Other key industry trends
- In terms of revenue, North America region accounted for 47.3% of the global longevity diagnostics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 989.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Longevity Diagnostics Market Scope
Longevity Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Altos Labs | View profile | 251-500 | San Francisco, California, United States, North America | https://altoslabs.com/ |
| WellnessFX | View profile | 11-50 | San Francisco, California, United States, North America | https://www.wellnessfx.com |
| Function Health | View profile | 11-50 | Austin, Texas, United States, North America | https://www.functionhealth.com |
| InsideTracker | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | http://insideTracker.com |
| Tally Health | View profile | 11-50 | New York, New York, United States, North America | https://www.tallyhealth.com |
| GlycanAge | View profile | 11-50 | Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe | https://glycanage.com |
| TruDiagnostic | View profile | 51-100 | Lexington, Kentucky, United States, North America | https://trudiagnostic.com |
| SiPhox Health | View profile | 11-50 | Burlington, Massachusetts, United States, North America | https://siphoxhealth.com |
| Elysium | View profile | 11-50 | New York, New York, United States, North America | http://www.elysiumhealth.com |
| Abbott | View profile | - | - | - |
| Nebula Genomics | View profile | 11-50 | San Francisco, California, United States, North America | https://www.nebula.org |
| Knovos | View profile | 251-500 | Fairfax, Virginia, United States, North America | https://www.knovos.com/ |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
North America longevity diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to longevity diagnostics market will help companies and investors design strategic landscapes.
Epigenetic age testing was the largest segment with a revenue share of 27.11% in 2025. Horizon Databook has segmented the North America longevity diagnostics market based on epigenetic age testing, telomere length analysis, multi-omics profiling, proteomics-based aging biomarkers, metabolomics testing, microbiome aging diagnostics, hormone & metabolic profiling covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America longevity diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America longevity diagnostics market databook
-
Our clientele includes a mix of longevity diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America longevity diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America longevity diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America longevity diagnostics market size, by country, 2021-2033 (US$M)
North America Longevity Diagnostics Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
